Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryuta Koike

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 20, 2011
[IMRT for esophageal neoplasms]Yasumasa Nishimura, Ryuta Koike
International Journal of Radiation Oncology, Biology, Physics|February 1, 2008
Concurrent chemoradiotherapy for esophageal cancer with malignant fistulaRyuta Koike, Yasumasa Nishimura, Kiyoshi Nakamatsu, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 30, 2011
Randomized clinical trial of postoperative strontium-90 radiation therapy for pterygia: treatment using 30 Gy/3 fractions vs. 40 Gy/4 fractionsKiyoshi Nakamatsu, Yasumasa Nishimura, Shuichi Kanamori, et al.
Japanese Journal of Clinical Oncology|August 13, 2003
Phase I study of weekly docetaxel infusion and concurrent radiation therapy for head and neck cancerMinoru Suzuki, Yasumasa Nishimura, Kiyoshi Nakamatsu, et al.
Japanese Journal of Clinical Oncology|September 2, 2003
Concurrent chemoradiotherapy with protracted infusion of 5-FU and cisplatin for postoperative recurrent or residual esophageal cancerYasumasa Nishimura, Ryuta Koike, Kiyoshi Nakamatsu, et al.
Japanese Journal of Clinical Oncology|June 25, 2005
Importance of the initial volume of parotid glands in xerostomia for patients with head and neck cancers treated with IMRTYasumasa Nishimura, Kiyoshi Nakamatsu, Toru Shibata, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 28, 2006
Analysis of interfractional set-up errors and intrafractional organ motions during IMRT for head and neck tumors to define an appropriate planning target volume (PTV)- and planning organs at risk volume (PRV)-marginsMinoru Suzuki, Yasumasa Nishimura, Kiyoshi Nakamatsu, et al.
Japanese Journal of Clinical Oncology|June 11, 2010
Definitive radiation therapy for moderately advanced laryngeal cancer: effects of accelerated hyperfractionationMitsuru Okubo, Yasumasa Nishimura, Toru Shibata, et al.
Radiology|October 16, 2004
Moderate versus high concentration of contrast material for aortic and hepatic enhancement and tumor-to-liver contrast at multi-detector row CTKazuo Awai, Masaaki Inoue, Yukinobu Yagyu, et al.
International Journal of Clinical Oncology|March 1, 2008
Treatment outcomes and dose-volume histogram analysis of simultaneous integrated boost method for malignant gliomas using intensity-modulated radiotherapyKiyoshi Nakamatsu, Minoru Suzuki, Yasumasa Nishimura, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 20, 2011
[IMRT for esophageal neoplasms]Yasumasa Nishimura, Ryuta Koike
International Journal of Radiation Oncology, Biology, Physics|February 1, 2008
Concurrent chemoradiotherapy for esophageal cancer with malignant fistulaRyuta Koike, Yasumasa Nishimura, Kiyoshi Nakamatsu, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 30, 2011
Randomized clinical trial of postoperative strontium-90 radiation therapy for pterygia: treatment using 30 Gy/3 fractions vs. 40 Gy/4 fractionsKiyoshi Nakamatsu, Yasumasa Nishimura, Shuichi Kanamori, et al.
Japanese Journal of Clinical Oncology|August 13, 2003
Phase I study of weekly docetaxel infusion and concurrent radiation therapy for head and neck cancerMinoru Suzuki, Yasumasa Nishimura, Kiyoshi Nakamatsu, et al.
Japanese Journal of Clinical Oncology|September 2, 2003
Concurrent chemoradiotherapy with protracted infusion of 5-FU and cisplatin for postoperative recurrent or residual esophageal cancerYasumasa Nishimura, Ryuta Koike, Kiyoshi Nakamatsu, et al.
Japanese Journal of Clinical Oncology|June 25, 2005
Importance of the initial volume of parotid glands in xerostomia for patients with head and neck cancers treated with IMRTYasumasa Nishimura, Kiyoshi Nakamatsu, Toru Shibata, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 28, 2006
Analysis of interfractional set-up errors and intrafractional organ motions during IMRT for head and neck tumors to define an appropriate planning target volume (PTV)- and planning organs at risk volume (PRV)-marginsMinoru Suzuki, Yasumasa Nishimura, Kiyoshi Nakamatsu, et al.
Japanese Journal of Clinical Oncology|June 11, 2010
Definitive radiation therapy for moderately advanced laryngeal cancer: effects of accelerated hyperfractionationMitsuru Okubo, Yasumasa Nishimura, Toru Shibata, et al.
Radiology|October 16, 2004
Moderate versus high concentration of contrast material for aortic and hepatic enhancement and tumor-to-liver contrast at multi-detector row CTKazuo Awai, Masaaki Inoue, Yukinobu Yagyu, et al.
International Journal of Clinical Oncology|March 1, 2008
Treatment outcomes and dose-volume histogram analysis of simultaneous integrated boost method for malignant gliomas using intensity-modulated radiotherapyKiyoshi Nakamatsu, Minoru Suzuki, Yasumasa Nishimura, et al.
Pageof 2